 |
Articles: Drug Trials |
Prior Articles
Roche to Commence Phase III Trials with Innovative
Treatment Designed to Lower Cardiovascular Risk
in Diabetes Patients with Recent Heart Attack
Roche, 06/10/09
Free full text
Results From Phase 1 Clinical Study of PEG-PAL in PKU and Update on Phase 2 Clinical Study
BioMarin, 06/10/09
Free full text
Telcagepant is a new oral treatment for migraine
Expert Opinion in Pharmacotherapy, 06/09/09 Abbott's TRILIPIX (fenofibric acid) in Combination with Rosuvastatin Calcium Helps Patients with Mixed Dyslipidemia and Type 2 Diabetes Meet American Diabetes Association Lipid Targets
Abbott, 06/09/09 Afinitor Phase II data show positive results for patients with multiple types of lymphoma, leading to Phase III trial
Novartis, 06/09/09
Free full text
Active Biotech Completes Patient Enrollment to TASQ Clinical Phase II study
Active Biotech, 06/09/09
Free full text
Pixantrone in Combination with Chemotherapy Regimens Produces Overall Response Rates of 58-74% with Complete Remission Rates of 37-57% in Relapsed/Refractory Aggressive or Indolent NHL
Cell Therapeutics, 06/09/09
Free full text
Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial
European Heart Journal, 06/09/09
Exclusive Author Commentary Large, long-term study shows Avandia has no increased overall cardiovascular risk compared to other commonly used diabetes medicines
GlaxoSmithKline, 06/08/09
Free full text
Rolofylline Did Not Demonstrate Efficacy for Acute Heart Failure in Clinical Trial
Merck & Co., 06/08/09
Free full text
New data from Boehringer Ingelheim's ongoing linagliptin trial programme show promising safety and efficacy results
Boehringer Ingelheim, 06/08/09
Free full text
Dapagliflozin Study Demonstrated Improved Glycemic Control In Type 2 Diabetes Patients Treated With High Doses of Insulin and Common Oral Anti-Diabetic Medicines
Bristol Myers-Squibb Company, 06/08/09
Free full text
Study Shows Consistent Use of Insulin Pump Therapy, Augmented with Continuous Glucose Monitoring, Results in Significant A1C Reductions
Medtronic, 06/08/09
Free full text
New Study Shows Nplate(R) Significantly Reduces Splenectomy Rate and Treatment Failure in Patients With Chronic ITP
Amgen, 06/08/09
Free full text
Comparison of SSRIs and SNRIs in major depressive disorder: a meta-analysis of head-to-head randomized clinical trials
Journal of Clinical Pharmacy and Therapeutics, 06/05/09 Inadequate planning and reporting of adjudication committees in clinical trials: Recommendation proposal
Journal of Clinical Epidemiology, 06/05/09 Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy
Trials, 06/05/09
Free full text
The evidence provided by a single trial is less reliable than its statistical analysis suggests
Journal of Clinical Epidemiology, 06/05/09 AstraZeneca studies show relief of nighttime heartburn and reduction in GERD-related sleep disturbances
AstraZeneca, 06/04/09
Free full text
Impact study showed longer valcyte (valganciclovir hydrochloride tablets) treatment demonstrated better protection against cytomegalovirus (cmv) disease one year post-transplant
Roche, 06/04/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
